Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000924976 | SCV001070503 | likely benign | Sphingolipid activator protein 1 deficiency | 2024-11-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001815460 | SCV002062919 | likely benign | not provided | 2021-12-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004958290 | SCV005479197 | likely benign | Inborn genetic diseases | 2024-07-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001825865 | SCV002087053 | likely benign | Metachromatic leukodystrophy | 2020-01-18 | no assertion criteria provided | clinical testing |